65 results
8-K
EX-99.1
CUE
Cue Biopharma Inc
9 May 24
Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
4:01pm
effects or other safety issues experienced by participants in clinical trials; its ability to secure required U.S. Food and Drug Administration (“FDA
8-K
EX-10.1
zug12
15 Nov 22
Cue Biopharma Announces $30 Million Private Investment in Public Equity (PIPE) Financing
4:30pm
8-K
EX-99.1
ujs4jo3h2hg7daxp2
15 Nov 22
Cue Biopharma Announces $30 Million Private Investment in Public Equity (PIPE) Financing
4:30pm
8-K
q6xprr
15 Nov 22
Cue Biopharma Announces $30 Million Private Investment in Public Equity (PIPE) Financing
4:30pm
8-K
sqwewhwlrox3jff6lwv9
30 Mar 22
Entry into a Material Definitive Agreement
4:10pm
8-K
EX-10.1
liiht3wf
30 Mar 22
Entry into a Material Definitive Agreement
4:10pm
8-K
EX-99.1
0bu079vyiq49ipq
15 Nov 21
Regulation FD Disclosure
7:57am
8-K
EX-1.1
1dy5kx5
1 Oct 21
Entry into a Material Definitive Agreement
5:01pm